Cell Robotics begins clinicals of laser skin perforator for blood sampling.
This article was originally published in The Gray Sheet
Executive Summary
CELL ROBOTICS BEGINS CLINICALS ON LASER SKIN PERFORATOR following FDA approval of an investigational device exemption for the study July 25. The single-site trial at University of New Mexico Medical School in Albuquerque will compare use of the laser to conventional stainless steel lancets for collecting capillary blood samples, and focus on any changes in blood chemistry from device use. Cell Robotics, Inc. expects to complete the study in four to six weeks.